Preferential IgH V4-34 gene segment usage in particular subtypes of B-cell lymphoma detected by antibody 9G4

Immunoglobulin heavy chain locus variable gene segment V4-34 (V H4.21) use in productive heavy chain (IgH) gene rearrangements has been described in a number of human reactive and autoimmune B cell responses, and has been shown to be frequently used in some series of cases of diffuse large cell lymp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 1998-11, Vol.29 (11), p.1317-1321
Hauptverfasser: Funkhouser, William K, Warnke, Roger A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Immunoglobulin heavy chain locus variable gene segment V4-34 (V H4.21) use in productive heavy chain (IgH) gene rearrangements has been described in a number of human reactive and autoimmune B cell responses, and has been shown to be frequently used in some series of cases of diffuse large cell lymphoma (DLCL). The 9G4 antibody is relatively specific for the V4-34 gene product and can be used to screen for cells that use V4-34 in their productive IgH locus rearrangements. The purposes of this study were to determine the sensitivity of the 9G4 antibody against DLCL cases known to use V4-34, then to screen a variety of human lymphoma types for 9G4 reactivity. Frozen tissue sections were cut from 118 cases of various human lymphomas. Generalized 9G4 membrane reactivity was identified in 78% of DLCL cases known to use V4-34. 9G4 reactivity varied by lymphoma type for the unknown cases, with diffuse large cell lymphoma (30%) and mantle cell lymphoma (28%) showing statistically significant differences ( P < .001) from the expected value of 6% V4-34 positivity in peripheral blood B cells. This nonrandom increased utilization of V4-34 in productive IgH locus rearrangements supports the hypothesis that Ig binding specificity may play a role in lymphomagenesis.
ISSN:0046-8177
1532-8392
DOI:10.1016/S0046-8177(98)90264-7